논문 상세보기

Anti-wrinkle Effect of PLA2-free Bee Venom against UVB-irradiated Human Skin Cells KCI 등재

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/292972
구독 기관 인증 시 무료 이용이 가능합니다. 4,200원
농업생명과학연구 (Journal of Agriculture & Life Science)
경상대학교 농업생명과학연구원 (Institute of Agriculture & Life Science, Gyeongsang National University)
초록

The use of bee venom (Apis mellifera L., BV) occasionally causes side effects such as inflammation and allergic reactions in the recipients. Several case reports also suggested the treatment of BV has some limitations in its clinical uses, due to the occurrence of dermal necrosis and anaphylatic reactions. It is generally understood that bee venom allergy is mainly the result of its allergic component, phospholipase A2 (PLA2). The present study was aimed to generate PLA2-free bee venom (PBV) and evaluate its efficacy as skin care and cosmetic preparation, comparing with original bee venom (BV). Our results showed that both BV and PBV exhibited significant protective effects in UVB-irradiated human keratinocyte (HaCaT) and human dermal fibroblast (HDF) cells and they also induced type I collagen synthesis in UVB-irradiated HDF cells except BV at 3 μg/ml. Furthermore, BV and PBV showed the inhibition of UVB-stimulated matrix metalloproteinase-1 (MMP-1), a major collagen degrading enzyme in skin. However, BV, unlike PBV, exhibited strong cytotoxicities in skin cells (both HaCaT and HDF) at its working concentrations of anti-wrinkle effect. The underlying cell signaling mechanisms of anti-wrinkle effects of BV and PBV were demonstrated by the activation of ERK1/2, and p38. Conclusively, PBV appears to be the bee venom of choice with less cytotoxicity and higher efficacy on UVB-irradiated skin cells in comparison with original bee venom (BV). Therefore, PBV can better be used as a cosmetic ingredient exhibiting excellent anti-wrinkle effect against photoaging than original BV.

저자
  • Hyunkyoung Lee(College of Veterinary Medicine, Gyeongsang National University)
  • Seong Kyeong Bae(College of Veterinary Medicine, Gyeongsang National University)
  • Min-Jung Pyo(College of Veterinary Medicine, Gyeongsang National University)
  • Yunwi Heo(College of Veterinary Medicine, Gyeongsang National University)
  • Choul Goo Kim(Chung Jin Biotech Co., Ltd., Hanyang University Business Center)
  • Changkeun Kang(College of Veterinary Medicine, Gyeongsang National University, Inst. of Agric. & Life Sci., Gyeongsang National University)
  • Euikyung Kim(College of Veterinary Medicine, Gyeongsang National University, Research Institutes of Life Science, Gyeongsang National University) Corresponding author